As Five9 prepares to report Q4 2025 results, Wall Street is scrutinizing whether the contact-center software leader can maintain its edge in an AI-driven market. The company's recent stock volatility and new partnerships highlight both opportunity and risk.
As the largest generation in U.S. history approaches retirement, Federal Reserve data reveals a stark divide in preparedness, with millions lacking any dedicated savings and median balances that may not sustain decades of post-work life.
While artificial intelligence reshapes the entry-level landscape, new data reveals that advanced degrees in human-centric fields like mental health counseling and law are not only resilient but experiencing surging demand, offering a clear path for graduates navigating economic uncertainty.
Argan Inc. reports record project backlog and strong financials, driving a significant stock rally. While management touts diversified industrial demand as a tailwind, the market debate now centers on the durability of this growth phase and the company's ability to convert its massive pipeline into sustained profit.
In a strategic move to address the data-to-action gap in retail, GOcxm has acquired Emotive Technologies, integrating the latter's Apex AI predictive platform into its core shopper engagement suite.
As the AI race intensifies, investors face a stark choice between Nvidia's foundational chip empire and Palantir's data analytics software. Valuation and long-term strategic positioning are key battlegrounds in this high-stakes comparison.
Automatic Data Processing (ADP) reported steady fourth-quarter growth, driven by demand for its HCM platforms. While CEO Maria Black pointed to record client satisfaction and international expansion, analysts pressed management on AI monetization, margin pressures, and a noted dip in small business retention.
Pfizer's Q4 2025 results surpassed profit expectations despite a slight revenue dip, as the pharma giant pivots its growth strategy towards next-generation therapies and cost discipline in a shifting market.
Sangamo Therapeutics secures a critical FDA Accelerated Approval pathway for its Fabry disease gene therapy ST-920, backed by positive Phase 1/2 data. As the company begins its rolling BLA submission, investors weigh promising clinical results against persistent financial risks and a history of dilution.
Biotech firm Perspective Therapeutics (CATX) has raised nearly $175 million in a follow-on equity offering, capitalizing on investor enthusiasm following promising early-stage data for its lead alpha-particle therapy candidate. The influx of cash alleviates immediate financial pressures but shifts the spotlight squarely onto upcoming clinical milestones and execution risks.
At the 2026 Kitchen & Bath Industry Show, MasterBrand's Omega line, in collaboration with Cambria, unveiled new high-design offerings. The move is seen as a deliberate step to elevate the brand's positioning within the competitive cabinetry market, though financial headwinds remain a key focus for investors.
Opera's strategic partnership with Tether to integrate USDT and Tether Gold into its MiniPay wallet, coupled with a significant upward revision of its 2025 revenue guidance, is positioning the browser company as a serious contender in the emerging markets fintech space. This move underscores a pivot from pure browsing to becoming a gateway for digital asset transactions.
Logistics firm Stord has taken over a key Quiet Logistics fulfillment center in Dallas, securing a pipeline of customers as American Eagle Outfitters winds down its third-party logistics subsidiary. The move marks another strategic acquisition for the rapidly growing company.
The U.S. Treasury Department is escalating its enforcement focus from individual crypto wallets to the underlying exchange infrastructure allegedly used by Iran to bypass sanctions, with new data revealing the scale of the activity.
All eyes are on Amazon as it prepares to report Q4 earnings, with options markets pricing in a significant stock move. Investors are keenly focused on updates regarding AWS momentum, AI infrastructure investments, and the balance between growth spending and recent cost-cutting measures.
As the artificial intelligence revolution intensifies, chipmakers Broadcom and Micron Technology are positioned at the center of a supply-demand imbalance, presenting a unique opportunity for investors despite recent market highs.
Amidst market jitters, Nvidia CEO Jensen Huang argues the AI boom is built on a fundamental technological shift, not speculation. A closer look at valuations and profitability suggests this rally differs starkly from the dot-com era.
A surge of new apartment construction in the Raleigh area is giving renters more options and negotiating power, with rents cooling notably in several key neighborhoods. We break down the data and the deals.
Palantir Technologies' shares surged nearly 7% following a blockbuster earnings report, fueled by a 66% jump in U.S. government revenue. The data analytics firm, a key Pentagon and intelligence community contractor, is riding a wave of increased defense spending, though its high valuation and controversial ICE surveillance work draw mixed reactions from investors and analysts.
The health insurance giant is rolling out an 'Agent Assist' tool to its 20,000+ call center workers, aiming to boost efficiency, accuracy, and consistency in member service while targeting over $100 million in operational savings.
